Cosmos Health Inc./$COSM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cosmos Health Inc.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Ticker
$COSM
Sector
Primary listing
Employees
163
Headquarters
Thessaloniki, Greece
Website
COSM Metrics
BasicAdvanced
$11m
-
-$0.59
4.12
-
Price and volume
Market cap
$11m
Beta
4.12
52-week high
$1.32
52-week low
$0.16
Average daily volume
12m
Financial strength
Current ratio
1.083
Quick ratio
0.631
Long term debt to equity
33.227
Total debt to equity
87.866
Interest coverage (TTM)
-5.51%
Profitability
EBITDA (TTM)
-16.5
Gross margin (TTM)
10.40%
Net profit margin (TTM)
-30.41%
Operating margin (TTM)
-25.75%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
-18.71%
Return on equity (TTM)
-92.33%
Valuation
Price to revenue (TTM)
0.102
Price to book
0.5
Price to tangible book (TTM)
0.79
Price to free cash flow (TTM)
-0.751
Free cash flow yield (TTM)
-133.21%
Free cash flow per share (TTM)
-0.267
Growth
Revenue change (TTM)
29.75%
Earnings per share change (TTM)
-40.24%
3-year revenue growth (CAGR)
11.87%
10-year revenue growth (CAGR)
45.18%
3-year earnings per share growth (CAGR)
-64.56%
10-year earnings per share growth (CAGR)
-26.68%
COSM News
AllArticlesVideos
Cosmos Health enters animal health market with C-Scrub brand
Proactive Investors·2 months ago
Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants
Accesswire·2 months ago
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.